JRJC [China Finance Online] 6-K: (Original Filing)

[China Finance Online Reports 2020 Second Quarter and First Six Months Unaudited Financial Results BEIJING, September 24, 2020 /PRNewswire/ -- China Finance Online Co. Limited ("China Finance Online", or the "Company", "we", "us" or "our") (NASDAQ GS: JRJC), a leading web-based financial services com]

JRJC [China Finance Online] 6-K: China Finance Online Reports 2020 Second Quarter and

[China Finance Online Reports 2020 Second Quarter and First Six Months Unaudited Financial Results BEIJING, September 24, 2020 /PRNewswire/ -- China Finance Online Co. Limited ("China Finance Online", or the "Company", "we", "us" or "our") (NASDAQ GS: JRJC), a leading web-based financial services com]

SOL [ReneSola] 6-K: (Original Filing)

[ReneSola Power Announces $5 Million Registered Direct Offering STAMFORD, CT, Sept. 23, 2020 /PRNewswire/ H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering. The gross proceeds from the registered direct offering are expected to be $5.0 million before deducting placemen]

By | 2020-10-01T01:50:58+00:00 September 24th, 2020|Categories: Chinese Stocks, SEC Original, SOL|Tags: , , , , , |0 Comments

SVA [SINOVAC BIOTECH] 6-K: (Original Filing)

[Sinovac Commences Phase III Clinical Trials for COVID-19 Vaccine Candidate in Turkey Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, announced today that it has recently commenced phase III clinical trials for its inactivate]

By | 2020-10-01T15:36:55+00:00 September 23rd, 2020|Categories: Chinese Stocks, SEC Original, SVA|Tags: , , , , , |0 Comments

SVA [SINOVAC BIOTECH] 6-K: Sinovac Commences Phase III Clinical Trials for COVID-19

[Sinovac Commences Phase III Clinical Trials for COVID-19 Vaccine Candidate in Turkey Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, announced today that it has recently commenced phase III clinical trials for its inactivate]

By | 2020-10-01T15:36:58+00:00 September 23rd, 2020|Categories: Chinese Stocks, SVA, Webplus ver|Tags: , , , , , |0 Comments

SVA [SINOVAC BIOTECH] 6-K: (Original Filing)

[Sinovac’s Coronavac, SARS-CoV-2 Vaccine (Vero Cell), Inactivated, Announces Approval for Phase I/II Clinical Trial in Adolescents and Children BEIJING, China, September 23, 2020 /Business Wire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutica]

By | 2020-10-01T15:36:44+00:00 September 23rd, 2020|Categories: Chinese Stocks, SEC Original, SVA|Tags: , , , , , |0 Comments

SVA [SINOVAC BIOTECH] 6-K: Sinovac’s Coronavac, SARS-CoV-2 Vaccine (Vero Cell), Inactivated, Announces

[Sinovac’s Coronavac, SARS-CoV-2 Vaccine (Vero Cell), Inactivated, Announces Approval for Phase I/II Clinical Trial in Adolescents and Children BEIJING, China, September 23, 2020 /Business Wire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutica]

By | 2020-10-01T15:36:47+00:00 September 23rd, 2020|Categories: Chinese Stocks, SVA, Webplus ver|Tags: , , , , , |0 Comments

SNP [CHINA PETROLEUM & CHEMICAL] 6-K: (Original Filing)

[This Form 6-K consists of: 1. 2. Announcement 1 (a joint stock limited company incorporated in the People’s Republic of China with limited liability) (Stock Code: 00386) Resignation of Director The board of directors (the " Board ") of China Petroleum & Chemical Corporation (" Sinopec Corp. " or the]

By | 2020-10-01T09:26:24+00:00 September 23rd, 2020|Categories: Chinese Stocks, SEC Original, SNP|Tags: , , , , , |0 Comments

SGOC [SGOCO] 6-K: (Original Filing)

[SGOCO Group, Ltd. Appoints New Director The Company today announced that the Board of Directors of the Company has appointed Mr. Mark Leonard Tan (“Mr. Tan”) as the director of the Company, effective on September 23, 2020 to replace Mr. Hok Fung Wai who notified his resignation from the Board, effec]

Skip to toolbar